Wednesday, June 22, 2022 12:46:46 AM
Headwinds:
- ongoing sector illiquidity, general market weakness and possible upcoming consumer recession.
- State regulatory and taxation stranglehold on the industry driving bankruptcies while emboldening/growing the illicit market.
- Federal legislative blockade on industry support and reform along with punitive 280e taxation clause.
- Cali outdoor supply glut hemorrhaging margins and will need a large amount of suppliers to come offline to reach the bottom.
Tailwinds:
- Proposed California cultivation tax moratorium as of July 1. If it passes, that is about $160 a pound or close to $6.4M in annual savings for Lowell.
- Q1 was low water mark for the LFS segment as they shift from outdoor clients to a more consistent supply source of indoor grown product.
- The team has done a remarkable job at reducing opex and managing their very tight cash position and appear on the brink of profitability.
- The Lowell 35 pre roll rollout this summer appears to be an industry disruptor setting a standard of exceptional quality for deep value that could steal significant share at a pricing point that only scaled up highly efficient operations could compete with.
- Continuing licensee success and expansion with very limited costs or marketing.
Recent LOWLF News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 06:44:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 04:35:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 09:17:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 09:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 12:37:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 12:34:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 12:30:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 09:00:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 07:03:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:22:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM